• Advocacy Work

  Questions about Fulcrum Phase 2 Clinical Trials for FSHD

  Posted by danielle-dani-liptak on October 22, 2019 at 8:39 am

  August of this year Fulcrum Therapeutics launched ReDUX4, a phase 2 clinical trial for people with facioscapulohumeral muscular dystrophy (FSHD). This is testing the safety and efficacy of a repurposed drug called losmapimod. The ReDUX4 trial has sites in the US, Canada, Germany, Spain, and France.

  Have you read the article on the MD News Columns page? Are you excited about the possibilities of a treatment? Did you participate in this study, what was it like? Share your experience with us!

  danielle-dani-liptak replied 4 years, 6 months ago 1 Member · 0 Replies

  • cure and treatment for MD
  • fulcrum for MD
  • MD awareness
  • medical studies
  • phase 2 trials for MD
  • studies and trials
• 0 Replies

Log In to Reply